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Conclusions: Conventional criteria for accelerator QA have 
been implemented in a practical software tool. Furthermore, 
new concepts like relative flatness, relative symmetry and 
relative depth dose (RDD) as alternative for PDD are also 
available. For FFF-beams gamma analysis may be used to 
compare with baseline profiles. This approach can also be 
used for 2D-arrays. Flexible configuration makes the tool 
compliant with institution policies. 
This tool, BistroMath, (http://bistromath.nl) can handle 
beam measurement data of all major vendors, automatically 
comparing data with stored reference data with a flexible 
and configurable user preferences. It is routinely used in the 
UMC Utrecht, free available and not related to any 
commercial party.  
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Purpose/Objective: A four year old male was presented with 
prostate rhabdomyosarcoma. Radiation therapy was required. 
A multi-disciplinary team of members from three cancer 
treatment centres and a university research centre was 
assembled to deliver a treatment method using 
brachytherapy.  
Materials and Methods: A hybrid LDR/HDR technique was 
developed, whereby LDR sources (I125 seeds) were used as 
temporary implants for a delivery lasting 4 days. This 
treatment option provided lower long term morbidity, and 
better sparing of surrounding organs in comparison to a 
contemporary HDR delivery (Ir192), external beam methods or 
surgery. The treatment involved the insertion of 6F plastic 
catheters in a HDR style implant, with the use of a custom 
made paediatric insertion template, which allowed a higher 
concentration of catheters and reduced the limitations of the 
smaller pubic arch on insertion. Fusion of ultrasound and CT 
was used as the imaging modality for the construction of the 
treatment plan. I125 seeds were loaded into 4F catheters in a 
required arrangement to fulfil the plan, with the 4F catheters 
placed inside the 6F catheters to achieve the implant.  
This study outlines the approach to the many challenges that 
needed to be overcome prior to attempting to deliver this 
novel technique: I125 seeds of a higher activity than standard 
were required to deliver the prescribed dose within a four 
day treatment window. How can traditional seed implant 
software be used to calculate the delivered dose when 
calculations are performed as an extrapolation to infinite 
time? How can the dose calculations be verified 
independently? How many seeds would be required and what 
activity is needed? Could changes be made to the plan mid-
delivery if inadequacies in the coverage were discovered? 
What are the safety implications for staff loading the higher 
activity seeds and for staff in the intensive care unit, where 
the delivery was performed? 
Results: The team successfully delivered the treatment after 
fulfilling the requirements of the above challenges. 16 
catheters were inserted into the patient, with 60 seeds of 
activity 4.40mCi each used in the treatment. 100 dummy 
seeds were initially loaded into the implanted catheters for 
CT imaging, giving the ability to see all possible locations for 
planning, from which 60 locations were selected. MRI scans 
were performed on day 2, in addition to daily X-rays, to 
ensure the integrity of the plan throughout the treatment. 
One adjustment to the plan was performed on day 2 of the 
treatment, with the movement of 5 seeds from high dose to 
low dose regions. 
Conclusions: The team successfully resolved the challenges, 
despite this being a novel technique. The hybrid LDR/HDR 
brachytherapy technique was used to treat this particular 
patient. A protocol for the delivery of this technique for 
future cases is under development for use in Australian 
centres, where an appropriate team can be assembled.  
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Purpose/Objective: To systematically compare the accuracy 
of planar (MapCHECK2) and helical (ArcCHECK) diode array 
measurements for pre-treatment QA. The effectiveness of 
each device was assessed for 2D phantom dose and 3D 
patient dose verification. 
Materials and Methods: 67 sliding window IMRT plans were 
measured using ArcCHECK (AC) and MapCHECK2 (MC) diode 
arrays (Sun Nuclear Corporation, Fl, USA). All MC 
measurements were performed at gantry 0° and water 
equivalent depth of 10 cm and 100 cm SDD. AC 
measurements were performed at the planned gantry angles 
